SynthesisBMC cancer2026

Efficacy and risk analysis of monotherapy and dual immunotherapy in dMMR/MSI-H metastatic colorectal cancer: a meta-analysis based on randomized controlled trials.

Shengqian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.